Esomeprazole and omeprazole could enhance the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) leading to enhanced adverse effects such as drowsiness, although the clinical relevance is reduced in most individuals – keep track of the affected person for adverse effects (e.If patient are unable to resume their normal oral m